Evaluation of serum neuron specific enolase levels among patients with primary and secondary burning mouth syndrome

1. Nasri-Heir, C, Zagury, JG, Thomas, D, et al. Burning mouth syndrome: Current concepts. J Ind Prosthod Soc 2015; 15: 300–307.
Google Scholar | Crossref | Medline2. Mock, D, Chugh, D. Burning mouth syndrome. Int J Oral Sci 2010; 2: 1–4.
Google Scholar | Crossref | Medline3. Ritchie, A, Kramer, J. Recent advances in the etiology and treatment of burning mouth syndrome. J Dent Res 2018; 97: 1193–1199.
Google Scholar | SAGE Journals | ISI4. Suga, T, Watanabe, T, Aota, Y, et al. Burning mouth syndrome: The challenge of an aging population. Geriatr Gerontol Int 2018; 18: 1649–1650.
Google Scholar | Crossref | Medline5. Kang, JH, Kim, YY, Chang, JY, et al. Relationships between oral MUC1 expression and salivary hormones in burning mouth syndrome. Arch Oral Biol 2017; 78: 58–64.
Google Scholar | Crossref | Medline6. Galli, F, Lodi, G, Sardella, A, et al. Role of psychological factors in burning mouth syndrome: A systematic review and meta-analysis. Cephalalgia 2017; 37: 265–277.
Google Scholar | SAGE Journals | ISI7. Lopez‐Jornet, P, Lucero‐Berdugo, M, Castillo‐Felipe, C, et al. Assessment of self‐reported sleep disturbance and psychological status in patients with burning mouth syndrome. J Eur Acad Dermatol Venereol 2015; 29: 1285–1290.
Google Scholar | Crossref | Medline | ISI8. Barry, A, O’Halloran, KD, Mckenna, JP, et al. Plasma Il‐8 signature correlates with pain and depressive symptomatology in patients with burning mouth syndrome: Results from a pilot study. J Oral Pathol Med 2018; 47: 158–165.
Google Scholar | Crossref | Medline9. Pekiner, FN, Demirel, GY, Gümrü, B, et al. Serum cytokine and t regulatory cell levels in patients with burning mouth syndrome. J Oral Pathol Med 2008; 37: 528–534.
Google Scholar | Crossref | Medline10. Suh, KI, Kim, YK, Kho, HS. Salivary levels of Il-1β, Il-6, Il-8, and Tnf-Α in patients with burning mouth syndrome. Arch Oral Biol 2009; 54: 797–802.
Google Scholar | Crossref | Medline | ISI11. Jääskeläinen, SK. Pathophysiology of primary burning mouth syndrome. Clin Neurophysiol 2012; 123: 71–77.
Google Scholar | Crossref | Medline | ISI12. Eusterman, VD, Meddles, KG, Viswanatha, B, et al. Burning mouth syndrome, http://Emedicine. Medscape. Com/Article/1508869-Overview# Showall (2019, accessed 14 January 2021).
Google Scholar13. Imamura, Y, Shinozaki, T, Okada‐Ogawa, A, et al. An updated review on pathophysiology and management of burning mouth syndrome with endocrinological, psychological and neuropathic perspectives. J Oral Rehab 2019; 46: 574–587.
Google Scholar | Crossref | Medline14. Lauria, G, Majorana, A, Borgna, M, et al. Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome. Pain 2005; 115: 332–337.
Google Scholar | Crossref | Medline | ISI15. Penza, P, Majorana, A, Lombardi, R, et al. “Burning tongue” and “burning tip”: The diagnostic challenge of the burning mouth syndrome. Clin J Pain 2010; 26: 528–532.
Google Scholar | Crossref | Medline16. Haque, A, Ray, SK, Cox, A, et al. Neuron specific enolase: A promising therapeutic target in acute spinal cord injury. Metab Brain Dis 2016; 31: 487–495.
Google Scholar | Crossref | Medline17. Li, J, Zhang, H, Xie, M, et al. NSE, a potential biomarker, is closely connected to diabetic peripheral neuropathy. Diabet Care 2013; 36: 3405–3410.
Google Scholar | Crossref | Medline18. Isgrò MA, Bottoni P, Scatena R. Neuron-specific enolase as a biomarker: Biochemical and clinical aspects. Advances in cancer biomarkers 2015; 125–143.
Google Scholar19. Li, J, Yan, M, Zhang, Y, et al. Serum neuron‐specific enolase is elevated as a novel indicator of diabetic retinopathy including macular oedema. Diabet Med 2015; 32: 102–107.
Google Scholar | Crossref | Medline | ISI20. Scala, A, Checchi, L, Montevecchi, M, et al. Update on burning mouth syndrome: Overview and patient management. Crit Rev Oral Biol Med 2003; 14: 275–291.
Google Scholar | SAGE Journals | ISI21. Kohorst, JJ, Bruce, AJ, Torgerson, RR, et al. A population-based study of the incidence of burning mouth syndrome. Mayo Clin Proc 2014; 89: 1545–1552.
Google Scholar | Crossref | Medline22. Riordain, RN, O’Dwyer, S, McCreary, C. Burning mouth syndrome – a diagnostic dilemma. Irish J Med Sci 2019: 188; 731–734.
Google Scholar23. Ślebioda, Z, Szponar, E. Burning mouth syndrome – a common dental problem in perimenopausal women. Menopause Rev 2014; 13: 198–202.
Google Scholar24. Dahiya, P, Kamal, R, Kumar, M. Burning mouth syndrome and menopause. Int J Prev Med 2013; 4: 15–20.
Google Scholar | Medline25. Gill, N, Ruparelia, P, Verma, O, et al. Comparative evaluation of unstimulated whole salivary flow rate and oral symptoms in healthy premenopausal and postmenopausal women-an observational study. J Ind Acad Oral Med Radiol 2019: 31; 234–238.
Google Scholar26. Puhakka, A, Forssell, H, Soinila, S, et al. Peripheral nervous system involvement in primary burning mouth syndrome – results of a pilot study. Oral Dis 2016: 22; 338–344.
Google Scholar | Crossref | Medline | ISI27. Lee, Y, Hong, I, Na, S, et al. Evaluation of salivary function in patients with burning mouth syndrome. Oral Dis 2015: 21: 308–313.
Google Scholar | Crossref | Medline | ISI28. Marino, R, Capaccio, P, Pignataro, L, et al. Burning mouth syndrome: The role of contact hypersensitivity. Oral Dis 2009; 15: 255–258.
Google Scholar | Crossref | Medline29. Sun, A, Lin, HP, Wang, YP, et al. Significant reduction of serum homocysteine level and oral symptoms after different vitamin‐supplement treatments in patients with burning mouth syndrome. J Oral Pathol Med 2013; 42: 474–479.
Google Scholar | Crossref | Medline30. Das Neves De Araújo Lima, E, Barbosa, NG, Dos Santos, ACS, et al. Comparative analysis of psychological, hormonal, and genetic factors between burning mouth syndrome and secondary oral burning. Pain Med 2016; 17: 1602–1611.
Google Scholar | Crossref | Medline31. Woda, A, Dao, T, Gremeau-Richard, C. Steroid dysregulation and stomatodynia (burning mouth syndrome). J Orofac Pain 2009; 23: 202–210.
Google Scholar32. Vaidya, R. Burning mouth syndrome at menopause: Elusive etiology. J Mid-Life Health 2012; 3: 3–4.
Google Scholar | Crossref33. Rukmini, J, Sachan, R, Sibi, N, et al. Effect of menopause on saliva and dental health. J Int Soc Prev Comm Dent 2018; 8: 529–533.
Google Scholar | Medline34. Chimenos-Kustner, E, Marques-Soares, M. Burning mouth and saliva. Medicina Oral 2002; 7: 244–253.
Google Scholar | Medline35. Lin, HP, Wang, YP, Chen, HM, et al. Significant association of hematinic deficiencies and high blood homocysteine levels with burning mouth syndrome. J Formosan Med Assoc 2013; 112: 319–325.
Google Scholar | Crossref | Medline36. Petruzzi, M, Lucchese, A, Campus, G, et al. Oral stigmatic lesions of gastroesophageal reflux disease (GERD). Rev Med Chil 2012; 140: 915–918.
Google Scholar | Crossref | Medline37. Sujatha, S, Jalihal, U, Devi, Y, et al. Oral pH in gastroesophageal reflux disease. Ind J Gastroenterol 2016; 35: 186–189.
Google Scholar | Crossref | Medline38. Aljanobi, H, Sabharwal, A, Krishnakumar, B, et al. Is it Sjögren’s syndrome or burning mouth syndrome? Distinct pathoses with similar oral symptoms. Oral Surg Oral Med Oral Pathol Oral Radiol 2017; 123: 482–495.
Google Scholar | Crossref | Medline39. Napeñas, JJ, Rouleau, TS. Oral complications of Sjögren’s syndrome. Oral Maxillofac Surg Clin North Am 2014; 26: 55–62.
Google Scholar | Crossref | Medline40. Gholami, N, Sabzvari, BH, Razzaghi, A, et al. Effect of stress, anxiety and depression on unstimulated salivary flow rate and xerostomia. J Dent Res Dent Clin Dent Prospects 2017; 11: 247–252.
Google Scholar41. Johnsson, M, Winder, M, Zawia, H, et al. In vivo studies of effects of antidepressants on parotid salivary secretion in the rat. Arch Oral Biol 2016; 67: 54–60.
Google Scholar | Crossref | Medline42. Yee, KM, Ross-Cisneros, FN, Lee, JG, et al. Neuron-specific enolase is elevated in asymptomatic carriers of Leber’s hereditary optic neuropathy. Investig Ophthalmol Visual Sci 2012; 53: 6389–6392.
Google Scholar | Crossref | Medline43. Yilmaz, Z, Renton, T, Yiangou, Y, et al. Burning mouth syndrome as a trigeminal small fibre neuropathy: Increased heat and capsaicin receptor TRPV1 in nerve fibres correlates with pain score. J Clin Neurosci 2007; 14: 864–871.
Google Scholar | Crossref | Medline | ISI44. Grémeau-Richard, C, Dubray, C, Aublet-Cuvelier, B, et al. Effect of lingual nerve block on burning mouth syndrome (stomatodynia): A randomized crossover trial. Pain 2010; 149: 27–32.
Google Scholar | Crossref | Medline | ISI45. Polcyn, R, Capone, M, Hossain, A, et al. Neuron specific enolase is a potential target for regulating neuronal cell survival and death: Implications in neurodegeneration and regeneration. Neuroimmunol Neuroinflamm 2017; 4: 254–257.
Google Scholar | Crossref | Medline46. Lotfy, M, Adeghate, J, Kalasz, H, et al. Chronic complications of diabetes mellitus: A mini review. Curr Diab Rev 2017; 13: 3–10.
Google Scholar | Crossref | Medline47. Guggenheimer, J, Moore, PA, Rossie, K, et al. Insulin-dependent diabetes mellitus and oral soft tissue pathologies. II. Prevalence and characteristics of candida and candidal lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol 2000; 89: 570–576.
Google Scholar | Crossref | Medline48. Cicmil, A, Govedarica, O, Lečić, J, et al. Oral symptoms and mucosal lesions in patients with diabetes mellitus type 2. Balkan J Dent Med 2017; 21: 50–54.
Google Scholar | Crossref49. Babu, K, Adiga, K, Dsouza, L, et al. Oral manifestations in diabetes mellitus. Dent 2019; 1: 28–30.
Google Scholar50. Arap, A, Siqueira, SR, Silva, CB, et al. Trigeminal pain and quantitative sensory testing in painful peripheral diabetic neuropathy. Arch Oral Biol 2010; 55: 486–493.
Google Scholar | Crossref | Medline | ISI51. Leite, RS, Marlow, NM, Fernandes, JK, et al. Oral health and type 2 diabetes. Am J Med Sci 2013; 345: 271–273.
Google Scholar | Crossref | Medline | ISI52. Zhai, H, Zhu, J. Application of NSE in diabetic peripheral neuropathy. J Modern Lab Med 2015; 4: 161–163.
Google Scholar53. Li, J, Yan, M, Zhang, Y, et al. Serum neuron‐specific enolase is elevated as a novel indicator of diabetic retinopathy including macular oedema. Diabetic Med 2015; 32: 102–107.
Google Scholar | Crossref | Medline |

留言 (0)

沒有登入
gif